In this interview from the 19th annual ANZICS Clinical Trials Group meeting in Noosa, I chat with Dr Yahya Shehabi about his proposed DICE 2 trial.
Dexmedetomidine is a fascinating drug that seems capable of solving many problems in the ICU.
In DICE 2, Yahya and his colleagues will look at the impact of the drug on renal function and related outcomes in patients undergoing high risk cardiac surgery.